Short-course Radiotherapy Combined With CAPOX and PD-1 Antibody Versus Long-course Chemoradiotherapy Combined With CAPOX for Early Low-lying Rectal Cancer

NCT06462053 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

134

Enrollment

OTHER

Sponsor class

Conditions

Early Low Rectal Cancer

Interventions

RADIATION: Short-course radiotherapy
DRUG: PD-1 antibody (Toripalimab)
RADIATION: Long-course radiotherapy
DRUG: Oxaliplatin
DRUG: Capecitabine

Sponsor

Fudan University